Chunghwa Chemical Synthesis & Biotech Co Ltd - Asset Resilience Ratio

Latest as of June 2024: 0.21%

Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has an Asset Resilience Ratio of 0.21% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 1762 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

NT$10.70 Million

≈ $337.11K USD Cash + Short-term Investments

Total Assets

NT$4.99 Billion

≈ $157.35 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2023)

This chart shows how Chunghwa Chemical Synthesis & Biotech Co Ltd's Asset Resilience Ratio has changed over time. See Chunghwa Chemical Synthesis & Biotech Co balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Chunghwa Chemical Synthesis & Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Chunghwa Chemical Synthesis & Biotech Co (1762) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$10.70 Million	0.21%
Total Liquid Assets	NT$10.70 Million	0.21%

Asset Resilience Insights

Limited Liquidity: Chunghwa Chemical Synthesis & Biotech Co Ltd maintains only 0.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Chunghwa Chemical Synthesis & Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Chunghwa Chemical Synthesis & Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Chunghwa Chemical Synthesis & Biotech Co Ltd (2009–2023)

The table below shows the annual Asset Resilience Ratio data for Chunghwa Chemical Synthesis & Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.21%	NT$10.70 Million ≈ $337.11K	NT$5.17 Billion ≈ $162.94 Million	+0.44pp
2022-12-31	-0.23%	NT$-10.70 Million ≈ $-337.11K	NT$4.56 Billion ≈ $143.80 Million	+0.01pp
2021-12-31	-0.24%	NT$-10.70 Million ≈ $-337.11K	NT$4.38 Billion ≈ $138.02 Million	+0.10pp
2020-12-31	-0.34%	NT$-10.70 Million ≈ $-337.11K	NT$3.15 Billion ≈ $99.15 Million	-0.03pp
2019-12-31	-0.31%	NT$-10.70 Million ≈ $-337.11K	NT$3.44 Billion ≈ $108.34 Million	+0.02pp
2018-12-31	-0.33%	NT$-10.70 Million ≈ $-337.11K	NT$3.22 Billion ≈ $101.49 Million	-0.02pp
2017-12-31	-0.31%	NT$-10.70 Million ≈ $-337.11K	NT$3.45 Billion ≈ $108.63 Million	+0.08pp
2016-12-31	-0.39%	NT$-10.70 Million ≈ $-337.11K	NT$2.73 Billion ≈ $85.87 Million	-0.02pp
2015-12-31	-0.37%	NT$-10.70 Million ≈ $-337.11K	NT$2.87 Billion ≈ $90.44 Million	-0.04pp
2014-12-31	-0.33%	NT$-10.70 Million ≈ $-337.11K	NT$3.21 Billion ≈ $101.05 Million	-1.39pp
2012-12-31	1.05%	NT$31.76 Million ≈ $1.00 Million	NT$3.02 Billion ≈ $95.00 Million	+1.04pp
2010-12-31	0.02%	NT$422.00K ≈ $13.30K	NT$2.37 Billion ≈ $74.68 Million	+0.00pp
2009-12-31	0.02%	NT$351.00K ≈ $11.06K	NT$2.31 Billion ≈ $72.85 Million	--

pp = percentage points

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology

Market Cap

$85.54 Million

NT$2.72 Billion TWD

Market Cap Rank

#19883 Global

#1172 in Taiwan

Share Price

NT$35.30

Change (1 day)

+1.73%

52-Week Range

NT$24.30 - NT$42.30

All Time High

NT$102.50